Maria Koehler

Directeur Médical

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 1 saleApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (3 ops.)

€8,113

Latest filing published 14 Mar 2025 for Repare Therapeutics Inc., €3,756. Read the official filing

Filing timeline

BuySale

Maria Koehler

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Maria Koehler: trading record in brief

Maria Koehler, listed as senior executive, appears in our data through filings on Repare Therapeutics Inc. shares, published by SEC (Form 4). In total, 8 filings cover trades dated from 10 December 2021 to 12 March 2025.

Sales make up the whole of the open-market record (3 sales, €8,113). Outside the open market, there are 2 share grants and 3 option exercises. So far in 2025, the count stands at no purchases and 1 sale.

The record was last updated on 14 March 2025 with an open-market sale (€3,756) in Repare Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.